Changes in expression levels of PV, GAD67 and KCC2 in the brain tissue of rats with schizophrenia induced by MK-801

LIU Yong; TANG Ya-Mei; ZHANG Xiang-Hui; ZHAO Jing-Ping

PDF(1348 KB)

Chinese Journal of Contemporary Pediatrics ›› 2012, Vol. 14 ›› Issue (11) : 869-874.

EXPERIMENTAL RESEARCH

Changes in expression levels of PV, GAD67 and KCC2 in the brain tissue of rats with schizophrenia induced by MK-801

LIU Yong, TANG Ya-Mei, ZHANG Xiang-Hui, ZHAO Jing-Ping

Author information +

History +

Abstract

OBJECTIVE: To study changes in the expression levels of parvalbumin (PV), glutamate decarboxylase 67 (GAD67) and K+-Cl- cotransporter 2 (KCC2) in the brain tissue of rats with schizophrenia (SZ) induced by dizocilpine (MK-801), and to investigate the mechanism involving gamma-aminobutyric acid (GABA) by which NMDA receptor blocker induces SZ in the perinatal period. METHODS: Thirty-six neonatal male Sprague-Dawley rats were randomly assigned to two batches on postnatal day 6. Each batch was divided into normal control (treated by 0.9% normal saline), SZ-development model (treated by subcutaneous injection of 0.1 mg/kg MK-801 on postnatal days 7-10; bid), and SZ-chronic medication model groups (treated by intraperitoneal injection of 0.2 mg/kg MK-801 on postnatal days 47-60; qd). On postnatal day 63, the brain tissue of the first batch of rats was obtained and then fixed with paraform for histological sections; expression levels of PV and GAD67 in the medial prefrontal cortex (mPFC) and hippocampus CA1 were measured by immunohistochemistry. Simultaneously, the second batch of rats was sacrificed and the mPFC and hippocampus were obtained and homogenized; expression levels of KCC2 in the mPFC and hippocampus were measured by Western blot. RESULTS: Expression levels of PV and GAD67 in the mPFC and hippocampus CA1 were significantly lower in the SZ-development and chronic medication model groups than in the normal control group (P<0.05). Expression levels of KCC2 in the mPFC and hippocampus were significantly lower in the SZ-development model group than in the SZ-chronic medication model and normal control groups (P<0.05).ConclusionsThe expression changes of PV and GAD67 in SZ can be simulated using the SZ development model induced by MK-801, which might affect the development of the GABA system in the PFC and hippocampus by downregulating KCC2 expression.

Key words

Schizophrenia / Development / Parvalbumin / Glutamate decarboxylase 67 / K+-Cl- cotransporter 2 / Rats

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LIU Yong, TANG Ya-Mei, ZHANG Xiang-Hui, ZHAO Jing-Ping. Changes in expression levels of PV, GAD67 and KCC2 in the brain tissue of rats with schizophrenia induced by MK-801[J]. Chinese Journal of Contemporary Pediatrics. 2012, 14(11): 869-874

References

［1］Mouri A, Noda Y, Enomoto T, Nabeshima T. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment［J］. Neurochem Int, 2007, 51(2-4): 173-184.

［2］Light GA, Hsu JL, Hsieh MH, Meyer-Gomes K, Sprock J, Swerdlow NR, et al. Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients［J］. Biol Psychiatry, 2006, 60(11): 1231-1240.

［3］Zhang ZJ, Reynolds GP. A selective decrease in the relative density of parvalbumin immunoreactive neurons in the hippocampus in schizophrenia［J］. Schizophr Res, 2002, 55(1-2): 1-10.

［4］Lee HH, Deeb TZ, Walker JA, Davies PA, Moss SJ. NMDA receptor activity downregulates KCC2 resulting in depolarizing GABAA receptor-mediated currents［J］. Nat Neurosci, 2011, 14(6): 736-743.

［5］Pellegrino C, Gubkina O, Schaefer M, Becq H, Ludwig A, Mukhtarov M, et al. Knocking down of the KCC2 in rat hippocampal neurons increases intracellular chloride concentration and compromises neuronal survival［J］. J Physiol, 2011, 589(Pt 10): 2475-2496

［6］Stefani MR, Moghaddam B. Transient N-methyl-D-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia［J］. Biol Psychiatry, 2005, 57(4): 433-436.

［7］Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Raeder H, et al. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities［J］. Biol Psychiatry, 2006, 59(8):721-729.

［8］尚云, 刘玲, 曹坤峰, 王多德, 王薇, 许浩. 宫内感染对早产新生大鼠脑发育的影响［J］. 中国当代儿科杂志, 2010, 12(7): 569-572.

［9］Hagberg H, Gressens P, Mallard C. Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults［J］. Ann Neurol, 2012, 71(4): 444-457.

［10］齐志业, 贺湘英, 李琪, 莫亚雄, 梁琨. 新生小鼠兴奋毒性脑损伤的神经行为功能研究［J］. 中国当代儿科杂志, 2009, 11(3): 191-193.

［11］Wedzony K, Fijal K, Mackowiak M, Chocyk A, Zajaczkowski W. Impact of postnatal blockade of N-methyl-D-aspartate receptors on rat behavior: a search for a new developmental model of schizophrenia［J］. Neuroscience, 2008, 153(4): 1370-1379.

［12］刘勇，唐亚梅, 蒲唯丹，张向晖，赵靖平. MK-801诱导的精神分裂症发育模型大鼠脑组织DA、DOPAC、Glu 和GABA浓度的变化［J］. 中南大学学报(医学版), 2011, 36(8): 712-719.

［13］Reynolds GP, Abdul-Monim Z, Neill JC, Zhang ZJ. Calcium binding protein markers of GABA deficits in schizophrenia—postmortem studies and animal models［J］. Neurotox Res, 2004, 6(1): 57-61.

［14］Romón T, Mengod G, Adell A. Expression of parvalbumin and glutamic acid decarboxylase-67 after acute administration of MK-801. Implications for the NMDA hypofunction model of schizophrenia［J］. Psychopharmacology (Berl), 2011, 217(2): 231238.

［15］Abekawa T, Ito K, Nakagawa S, Koyama T. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats［J］. Psychopharmacology (Berl), 2007, 192(3): 303-316.

［16］Woo TU, Walsh JP, Benes FM. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder［J］. Arch Gen Psychiatry, 2004, 61(7): 649-657.

［17］Paulson L, Martin P, Persson A, Nilsson CL, Ljung E, Westman-Brinkmalm A, et al. Comparative genome-and proteome analysis of cerebral cortex from MK-801-treated rats［J］. J Neurosci Res, 2003, 71(4): 526-533.

［18］Rivera C, Voipio J, Payne JA, Ruusuvuori E, Lahtinen H, Lamsa K, et al. The K+/Cl-co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation［J］. Nature, 1999, 397(6716): 251-255.

［19］Rivera C, Voipio J, Kaila K. Two developmental switches in GABAergic signalling: the K+-Cl-cotransporter KCC2 and carbonic anhydrase CAVII［J］. J Physiol, 2005, 562(Pt 1): 27-36.

［20］du Bois TM, Huang XF. Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia［J］. Brain Res Rev, 2007, 53(2): 260-270.